Leadership Team

Neopharma Technologies Ltd, an Australian public company, is pioneering the multi-billion-dollar global Point-of-Care (POC) health testing market with NEOVAULT®,

an AI-powered, touch-driven, paperless testing platform complemented by a comprehensive range of advanced rapid test kits.

With innovation at its core, Neopharma is redefining healthcare diagnostics through precision, scalability, and customer stickiness, transforming how workplace safety, healthcare, and productivity intersect.

Book A Demo

Vision Statement

Neopharma Technologies aims to be the recognized global leader for innovative drug-of-abuse health-care technologies. To promote a healthier and safer world.

Mission Statement

To have NEOVAULT® become the world's default digital scoring platform.

Marcus L'estrange

Executive Chairman - Neopharma Technologies Ltd.

Marcus is an engineer who has extensive experience in the IT industry, the Mining industry, the Oil and Gas industry, and the Environmental industry. He has been involved with the start-up of several successful companies within these sectors. He has a diverse range of skills as an engineer as well as in sales and marketing and business development. Marcus is the Managing Director of Raptor Global Corporation Ltd, an Australian public company with an Australian Financial Services License (AFSL) that provides corporate services to assist companies to grow globally. Marcus was also previously the Chairman of Comaro, an ASX listed IT company.